Amit Hasija
Director of Finance/CFO bei MILESTONE PHARMACEUTICALS INC.
Vermögen: 7 310 $ am 31.03.2024
Profil
Amit Hasija is currently the CFO & Executive VP-Corporate Development at Milestone Pharmaceuticals, Inc. He is also the Treasurer at Milestone Pharmaceuticals USA, Inc. Previously, he worked as an Operations Manager at Merck & Co., Inc. from 1995 to 2000.
From 2012 to 2017, he was the Vice President-Pharmaceutical Business Development at Sanofi.
He then served as the Chief Financial & Business Officer at Fulcrum Therapeutics, Inc. from 2017 to 2019.
Mr. Hasija received his undergraduate degree from Drexel University in 1995 and his MBA from The Leonard N Stern School of Business in 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2023 | 4 084 ( 0,01% ) | 7 310 $ | 31.03.2024 |
Aktive Positionen von Amit Hasija
| Unternehmen | Position | Beginn |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director of Finance/CFO | 09.09.2019 |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The private company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Treasurer | - |
Ehemalige bekannte Positionen von Amit Hasija
| Unternehmen | Position | Ende |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Director of Finance/CFO | 01.01.2019 |
| SANOFI | Corporate Officer/Principal | 01.01.2017 |
| MERCK & CO., INC. | Chief Operating Officer | 01.01.2000 |
Ausbildung von Amit Hasija
| Drexel University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANOFI | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The private company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Health Technology |
